OnabotulinumtoxinA in the Management of Psychogenic Dystonia

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 15, 2016

Primary Completion Date

May 30, 2017

Study Completion Date

June 30, 2017

Conditions
Torticollis, Dystonia
Interventions
BEHAVIORAL

CBT

All participating subjects will start a 12-week CBT treatment program. These consist of weekly 1-hour CBT sessions led by a cognitive therapist. Assessments will be repeated at week 16. All PsyD subjects will undergo a 15-minute, structured diagnostic interview (Mini International Neuropsychiatric Interview (MINI)) developed to screen for axis I DSM-IV and ICD-10 psychiatric disorders. We will also use two clinician-rated instruments to assess comorbid psychopathology in PsyD patients, the 17-item Hamilton Depression Rating Scale (HAM-D), to evaluate for depressed mood, vegetative and cognitive symptoms of depression; and the 14-item Hamilton Anxiety Rating Scale (HAM-A) to evaluate psychic and somatic anxiety. These scales will be administered as part of a structured interview.

Trial Locations (1)

45267

Alberto Espay, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER

NCT02618889 - OnabotulinumtoxinA in the Management of Psychogenic Dystonia | Biotech Hunter | Biotech Hunter